A 22 Gene-expression Assay, Decipher® (GenomeDx Biosciences) to Predict Five-year Risk of Metastatic Prostate Cancer in Men Treated with Radical Prostatectomy.
- Resource Type
- Article
- Source
- PLoS Currents; 2015, p21-28, 8p
- Subject
- Language
- ISSN
- 21573999